We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Caraco Pharmaceutical Laboratories, Ltd. Common Stock | AMEX:CPD | AMEX | Ordinary Share |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
From Jun 2019 to Jun 2024
The U.S. Food and Drug Administration on Thursday said it seized more than 30 generic drugs made by Caraco Pharmaceutical Laboratories Ltd. (CPD) after the agency found manufacturing defects at company plants, including oversized tablets.
Patients taking any generic drugs made by Detroit-based Caraco should continue taking them, said Deborah Autor, director of the FDA's office of compliance in its drug division. The company makes a wide variety of drugs, including the popular diabetes medicine, metformin, and the pain reliever tramadol.
Autor said patients may not realize the generic drug they are taking is made by Caraco, but added that any defective drugs have already been recalled or are seized.
The FDA seized the products after Caraco's "continued failure" to ensure the quality of its manufacturing processes, Autor said.
The FDA said the seizure may create a shortage of one medicine, choline magnesium trisalicylate oral tablets, commonly used as pain relievers. In that instance, physicians should switch patients to a safe alternative.
-By Jared A. Favole, Dow Jones Newswires; 202.862.9207; jared.favole@dowjones.com
1 Year Caraco Chart |
1 Month Caraco Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
